Good News for SCA27b

[wobblybee]

Solaxa has announced plans to conduct a phase 3 clinical trial of their drug SLX-100 (repurposed 4-Aminopyridine) for Spinocerebellar ataxia 27B (SCA27B). The trial will be based in the US, but additional trial sites are to be announced later this year.

Read more on our website.

#AtaxiaResearch #AtaxiaPharma #CerebellarAtaxia #SCA27b #Solaxa

[paul456]

Thanks Mrs Bee you’re the foundation of knowledge on this fantastic website 😊 x

[wobblybee in reply to paul456]

🙂I’m hoping…to be tested for SCA27b…when the test is available in the UK

[7151 in reply to wobblybee]

Interessted

[wobblybee in reply to 7151]

Someone told me they live in Mexico (where the test is not available)…but a relative arranged for them to have it done via Canada.

It is available in the U.S. and Canada.

[paul456 in reply to wobblybee]

I hope it goes well and in your favour so good luck my friend x

[7151]

Thankyou so not France xx

[wobblybee in reply to 7151]

Genetic testing for the repeat expansion in the FGF14 gene (SCA27B) is available in some diagnostic laboratories, both in the United States and in Europe, and can be performed for clinical testing purposes.

You will need to check this with your own Neurologist.

🙂This link gives information about SCA27B

ataxia.org/sca27b/